VC-Backed Verrica Pharmaceuticals Joins June IPO Parade
Verrica Pharmaceuticals Inc., a venture-backed medical technology company developing treatments for skin diseases and warts, launched an estimated $75 million initial public offering on Tuesday, joining at least five companies lining...To view the full article, register now.
Already a subscriber? Click here to view full article